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GCBCs are exceptional among activated lymphocytes in that, once GCs reach peak size, they undergo neither expansion in net cell number nor effector differentiation. Instead, the GC reaction reaches a steady-state number of GCBCs, with proliferation balanced by cell death, engendering intense clonal selection [1] [2] [3] . Further, during the GC reaction, small numbers of long-lived memory B and plasma cells are differentiated 4 . To accomplish these tasks, it is likely that GCBCs must be reprogrammed to a 'third state' that is distinct from either naive or effector-activated B cells. Indeed, by expressing various transcriptional regulators, most notably the transcription factor B cell lymphoma 6 protein (Bcl-6), GCBCs alter expression of a large number of genes and remodel their epigenome [5] [6] [7] . As a consequence, it is reasonable to think that B cell signal interpretation is also rewired during the GC reaction.
Our laboratory and others have been studying how GCBCs respond to environmental cues differently from other B cell lineages. These signals include adhesion and cell-cell interacting molecules, cytokines and antigen [8] [9] [10] [11] [12] [13] . We have focused on how signals that drive antigen selection are interpreted differently in GCBCs compared with other B cells. In naive B cells (NBCs), BCR signals trigger the phosphorylation of immunoglobulin-αβ immunoreceptor tyrosine activation motifs by the Src-family kinase LYN, leading to the activation of the kinase SYK. These events initiate the signalosome formation and the activation of multiple downstream pathways 14 .
Most notably, we found that BCR signals are markedly attenuated and qualitatively altered in GCBCs compared with NBCs 15, 16 . SYK kinase phosphorylation is much reduced, resulting in little downstream activation of the transcription factor nuclear factor-κB (NF-κB). The phosphatidylinositol-3-OH kinase (PI3K)-AKT signaling pathway is also altered, with reduced generation of p-S473 AKT and downstream kinase target phosphorylated (p-) S6 (p-S6), yet with strong phosphorylation of the AKT target FOXO1 transcription factor, which plays a critical role in antigen-driven GCBC selection [16] [17] [18] . We recently showed that this limited BCR-mediated downstream signal must cooperate with CD40 signals, which are also rewired to attenuate PI3K but maintain nuclear factor-κB transduction, to synergistically induce c-Myc and support positive selection of GCBCs 16, [19] [20] [21] . Although attenuation of BCR signaling in GCBCs is critical for survival and selection of cells in this site, little is known about the mechanisms by which GCBCs actually rewire their BCR signaling apparatus. We previously implicated increased phosphatase activity in this process and obtained evidence that both SHP-1 and SHIP-1 were potentially more active in GCBCs 15 . However, beyond this, the specific mechanisms for BCR signal attenuation and remodeling of PI3K-AKT signaling have not been elucidated.
Here, we identify a GC-specific AKT signaling network and demonstrate that it functions in a negative feedback loop to activate negative regulators of upstream BCR signaling. These studies also revealed several previously unknown targets of AKT that are enzymes and show that the phosphorylation of these yields increased enzymatic activity. We further demonstrate how AKT signaling is differentially targeted in GCBCs versus NBCs, which is due, at least in part, to GC-specific modulation of PI3K signals. We found that GCBCs express high amounts of PTEN, which leads to reduced abundance of phosphatidylinositol-(3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 ) but increased phosphatidylinositol-(4,5)-bisphosphate (PtdIns(4,5)P 2 ) generation on BCR ligation. Nonetheless, GCBCs express high amounts of PDK1, which can sensitively detect PtdIns(3,4,5)P 3 . Combined, these features result in robust AKT T308 phosphorylation but attenuated S473 phosphorylation, 
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leading to generation of a GC-specific AKT target profile. These studies thus provide insights into both PI3K-AKT signaling biology and the mechanism by which GCBCs retune BCR signaling to promote affinity selection.
Results
Phosphorylation of AKT is altered in GCBCs.
We previously showed that signals regulating FOXO1 and the metabolic checkpoint kinase mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) are rewired in GCBCs compared with NBCs 16 . Because both FOXO1 and mTORC1 are regulated by AKT, we hypothesized that AKT signaling in GCBCs would be reprogramed to alter these downstream pathways. We previously found that AKT S473 was poorly phosphorylated in both unstimulated NBCs and GCBCs 16 . Here, we found that, in cells isolated directly ex vivo, total AKT protein amounts were elevated in GCBCs and that AKT T308 was naturally phosphorylated to a greater extent in GCBCs than in NBCs (Fig. 1a,b and Supplementary Fig. 1a,b) . PDK1 is the upstream kinase for AKT T308 phosphorylation and phosphorylation of PDK1 at S241 is essential for its kinase activity 22 . We found that both total and S241 p-PDK1 were more abundant in GCBCs compared with NBCs (Fig. 1c) . As expected from our prior report 16 , AKT S473 phosphorylation was attenuated and transient in GCBCs on BCR stimulation (Fig. 1d) . In contrast, BCR signaling induced robust AKT T308 phosphorylation in GCBCs, comparable with that seen in NBCs (Fig. 1d) , despite the fact that BCR signaling in general is markedly attenuated in the GCBCs 15, 16 (Fig. 1e) . These findings suggest that elevated PDK1 expression and activity in GCBCs might compensate for an attenuated upstream signal to enable efficient AKT p-T308 generation.
Higher PTEN restrains AKT S473 phosphorylation in GCBCs.
We then asked why AKT S473 phosphorylation in GCBCs is dampened. AKT S473 phosphorylation is catalyzed by mTORC2, which The ratios were normalized to those of NBCs, given a value of 1. b, Splenocytes from immunized MEG mice (n = 3) were instantly fixed in 1.5% PFA and then analyzed by flow cytometry; lower graph shows fold change of median fluorescence intensity (MFI) and was normalized to NBCs as 1. c, Immunoblot for p-PDK1(S241) and total PKD1 in purified MEG NBCs and GCBCs (n = 2); lower graphs show the quantitation of bands as in b. The ratios were normalized to those of NBCs, given a value of 1. d, Total splenocytes from immunized MEG mice (n = 3) were stimulated with anti-IgM for the indicated time points, and p-AKT in GCBCs and NBCs was analyzed by flow cytometry. e, Purified MEG NBCs and GCBCs (n = 2) were rested for 40 min and stimulated with anti-IgM for indicated time points, and cell lysates were analyzed by immunoblot. Data represent two independent experiments with cells pooled from two mice per group in each experiment (a,c,e) or three independent experiments with one mouse tested in each experiment (b,d). [23] [24] [25] [26] ). We hypothesized that PtdIns(3,4,5)P 3 generation in GCBCs is controlled to allow efficient activation of PDK1, but not mTORC2. PtdIns(3,4,5)P 3 generation requires PI3K and in B cells the catalytic subunit p110δ is the major isoform mediating antigen-dependent BCR signaling 27 . We found that GCBCs expressed more, not less, p110δ protein than NBCs ( Supplementary Fig. 2 ), suggesting the rewired signaling in GCBCs is not due to reduced expression of the catalytic subunit of PI3K. In contrast, PTEN, which negatively regulates AKT activation by converting PtdIns(3,4,5)P 3 to PtdIns(4,5)P 2 28 , was more highly expressed in GCBCs than in NBCs (Fig. 2a) . The finding of elevated PTEN protein in GCBCs suggested that the balance between PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 might differ between NBCs and GCBCs. To test this, we measured generation of PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 as a function of time after BCR ligation. Compared with NBCs, GCBCs generated less PtdIns(3,4,5)P 3 , which returned to baseline within 5 min or less, yet GCBCs accumulated more PtdIns(4,5)P 2 ( Fig. 2b ), in keeping with higher PTEN amounts in GCBCs. The kinetics of PtdIns(3,4,5)P 3 generation on BCR ligation correlated well with attenuated BCR signaling and AKT S473 phosphorylation (Figs. 1d,e and 2b), further suggesting that high PTEN expression in GCBCs might restrain AKT S473 phosphorylation by inhibiting PtdIns(3,4,5)P 3 generation and favoring generation of PtdIns(4,5)P 2 . To test this, we used the PTEN inhibitor SF1670. Acute inhibition of PTEN significantly increased PtdIns(3,4,5) P 3 and PtdIns(3,4)P 2 generation in GCBCs on BCR stimulation, whereas it resulted in a significant decrease in the PTEN-dependent product of PtdIns(3,4,5)P 3 hydrolysis, PtdIns(4,5)P 2 (Fig. 2c) . These results were commensurate with our previous finding that SHIP-1 activity is elevated in GCBCs
15
; SHIP-1 could limit the accumulation of PtdIns(3,4,5)P 3 by converting PtdIns(3,4,5)P 3 into PtdIns(3,4)P 2 . Immunoblot was performed on cell lysates using the AKT phosphosubstrate antibody. One representative from two independent experiments is shown; cells were pooled from four to nine mice in each experiment. b, A Venn diagram was constructed to depict the number of AKT phosphosubstrates enriched in NBCs, activated NBCs, GCBCs and activated GCBCs using the criteria described in the Methods from two independent experiments with cells pooled from three to five mice in each experiment. c, AKT substrates that were specific to NBCs, activated NBCs, GCBCs or activated GCBCs were compared with the whole mouse proteome using a binomial test for each gene ontology and pathway term in the PANTHER software package to calculate the probability (P value) that the number of genes observed in each category occurred by chance.
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More importantly, pretreatment with SF1670 increased BCR signalinduced AKT S473 phosphorylation in GCBCs (Fig. 2d) , which is dependent on PtdIns(3,4,5)P 3 stimulation of mTORC2 activity. PTEN inhibition also increased p-S6 in GCBCs (Fig. 2d ). These findings indicate that suppression of the AKT-mTORC1-S6 axis is mechanistically linked to high PTEN activity in GCBCs.
AKT targets different pathways in GCBCs compared with NBCs.
Previous work demonstrated that differential phosphorylation regulates AKT substrate specificity [29] [30] [31] . Because GCBCs and NBC differ in AKT p-T308 and p-S473, we asked whether AKT substrates differ between NBCs and GCBCs. Immunoblotting using an AKT phosphosubstrate antibody that specifically recognizes the p-AKT substrate motif (RXRXXS*/T*) showed that the substrates of AKT in GCBCs qualitatively differed from NBCs, as well as activated non-GCBCs ( Fig. 3a and Supplementary Fig. 1b) .
To obtain a deeper understanding of the GCBC-specific AKT signaling network, we used beads coated with AKT phosphosubstrate antibody to immunoprecipitate AKT-phosphorylated substrates from lysates derived from fresh or BCR-stimulated NBCs and GCBCs, followed by a quantitative mass spectrometric assay (Supplementary Fig. 3 and Supplementary Table 1) . We identified 33 unique AKT substrates in BCR-activated NBCs and 63 in activated GCBCs, with other patterns of substrate sharing depicted in the Venn diagram (Fig. 3b ). In these cell type-specific AKT substrates, we found that AKT preferentially phosphorylated proteins involved in regulating the actin cytoskeleton in NBCs (Fig. 3c) . Interestingly, in GCBCs, AKT preferentially phosphorylated proteins with functions related to cell control, including transcriptional regulation, RNA processing and signal transduction (Fig. 3c) .
Together, these results demonstrate that the AKT kinase signaling network is rewired in GCBCs compared with NBCs.
AKT targets proximal BCR signaling regulators in GCBCs.
Given that BCR signaling is dampened in GCBCs 15, 16, 32, 33 , it was interesting that GCBC-specific AKT targets included negative regulators of BCR signaling, most notably CSK, SHP-1 and HPK1 (Fig. 4a) . To evaluate the expression of these three proteins, along with other relevant proteins in the BCR/PI3K signaling cascade, we performed immunoblot analysis with cell lysates of NBCs and GCBCs isolated directly ex vivo ( Supplementary Figs. 1b and 2 ). We found that total protein amounts of CSK and HPK1 were higher in GCBCs than NBCs ( Supplementary Fig. 2 ). CSK is the major kinase for the inhibitory tyrosine of LYN, which when phosphorylated maintains LYN in an inactive conformation 34 . SHP-1 is a phosphatase for multiple activating P-Tyr modifications, including on SYK and BLNK 35 . HPK1 is a kinase for BLNK, the phosphorylation of which by HPK1 inhibits its linker activity for BCR signal transduction 36 . The proteomics screen also identified that ARP2, a subunit in the ARP2/3 complex that regulates actin polymerization 37 , was phosphorylated by AKT in activated NBCs, but not GCBCs (Fig. 4a ).
NBCs and GCBCs were BCR stimulated with or without an AKT inhibitor, and immunoblotting was used to detect proteins that were immunoprecipitated by the AKT phosphosubstrate antibody, to confirm that these proteins were AKT substrates (Fig. 4b ). In agreement with the mass spectrometry results, CSK, SHP-1 and HPK1 were immunoprecipitated by this antibody only in GCBCs, validating these proteins as GCBCs-specific AKT substrates (Fig. 4b ). Probably because of the different nature of the assays, AKT-dependent phosphorylation of SHP-1 and HPK1 was found only in stimulated GCBCs by immunoblotting, whereas the mass spectrometric screening detected it in stimulated and unstimulated GCBCs. Immunoblotting detected ARP2 as an AKT substrate in NBCs only (Fig. 4b ), again consistent with the mass spectrometry assay. These results were validated by AKT inhibition, which blocked immunoprecipitation of all these proteins (Fig. 4b , right lanes). We included LYN as a negative control, which was not identified by mass spectrometry screening. As expected, LYN was not immunoprecipitated by the AKT phosphosubstrate antibody under any of the conditions tested (Fig. 4b) .
To further confirm results from the mass spectrometry assay, we performed in vitro kinase assays with recombinant activated AKT and found that AKT could effectively phosphorylate recombinant CSK, SHP-1 and HPK1 when adenosine triphosphate (ATP) was present (Fig. 4c) . As a negative control, recombinant AKT did not phosphorylate recombinant LYN in vitro. Together, our mass spectrometry screening and validation experiments suggest that AKT specifically phosphorylates at least three negative regulators of BCR signaling in GCBCs, but not NBCs.
AKT phosphorylation enhances negative regulator activity. Next, we used mass spectrometry to identify potential AKT phosphorylation sites on CSK, SHP-1 and HPK1, followed by functional assays to determine the consequences of phosphorylation. CSK was phosphorylated by AKT at S284 (Fig. 5a ). Phosphorylation of S284 was modeled onto the CSK-c-SRC crystal structure 38 , which suggested that phosphorylation would enhance the binding between CSK and its substrate, and thus might increase CSK kinase activity on LYN and other Src family kinases. We found that recombinant CSK that had been phosphorylated by AKT indeed had a 7-fold higher rate for phosphorylating LYN at Y507 than unphosphorylated CSK Articles NATuRE IMMuNoLoGY (Fig. 5b) . AKT phosphorylated SHP-1 on T394, which is within the catalytic domain (Fig. 5c) , suggesting functional impact. In fact, enzymatic activity of AKT-phosphorylated SHP-1 was increased 5-fold compared with unmodified SHP-1 (Fig. 5d) . This is also consistent with reported increased SHP-1 tyrosine phosphatase activity in GCBCs 15 . HPK1 phosphorylates BLNK on T152, which downmodulates BCR signaling 36 . However, the effect of phosphorylation of HPK1 by AKT has not been documented. We found that AKT-catalyzed phosphorylation sharply increased the activity of HPK1 for phosphorylating BLNK (Fig. 5e) . Hence, in each case, AKT-dependent phosphorylation increased the enzymatic activity of negative regulators of BCR signaling.
PTEN inhibition alters AKT signaling networks in GCBCs.
To investigate whether elevated PTEN expression in GCBCs is essential for maintaining the GCBC-specific AKT signaling network, we pretreated GCBCs or NBCs with PTEN inhibitor (SF1670) or dimethylsulfoxide (DMSO) before stimulation. We then immunoprecipitated AKT phosphosubstrates from cell lysates and performed quantitative mass spectrometric analysis ( Supplementary Fig. 3 and Supplementary Table 2) . A PANTHER pathway analysis demonstrated that PTEN inhibition substantially altered AKT signaling networks in GCBCs, with ontogenies of signaling, transcription and RNA processing manifesting major effects ( Fig. 6a and Supplementary Fig. 4 ). Specifically, PTEN inhibition reduced the level of AKT phosphorylation of CSK, SHP-1 and HPK1 in GCBCs (Fig. 6a,b) . On the other hand, AKT-catalyzed ARP2 phosphorylation was increased by PTEN inhibition in GCBCs (Fig. 6a,b) . These data link GCBC-specific alterations observed in AKT substrates to PTEN-dependent regulation of phosphatidylinositol phosphate species generation.
AKT inhibition enhances proximal BCR signaling in GCBCs.
The proteomic and in vitro kinase assays presented earlier indicated that AKT in GCBCs could enhance at least three important negative regulators of BCR signaling. We therefore hypothesized that AKT activity in GCBCs negatively controls upstream BCR signaling. The hypothesis predicts that an AKT-specific inhibitor would enhance 
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NATuRE IMMuNoLoGY the response to BCR stimulation specifically in GCBCs. Remarkably, AKT inhibition significantly enhanced the amount of active LYN in GCBCs, as measured by the ratio of activating-to-inhibitory tyrosine phosphorylation (Y396/Y507) 34, 39 (Fig. 7a) . The overall phosphorylation of SYK is a reflection of both LYN activity and SHP-1-mediated phosphatase activity. Our results and model predicted that AKT inhibition would lead to reduced activities of CSK and SHP-1, in turn leading to more LYN kinase activity on SYK and less phosphatase activity to hydrolyze p-SYK. Consistent with this, AKT inhibition resulted in notably higher and more persistent amounts of p-SYK in BCR-stimulated GCBCs (Fig. 7a) . To indirectly assess the functional effects of AKT inhibition on HPK1 and the resulting effects on generation of signals downstream of BLNK, we measured the generation of both p-BTK and phosphorylated phospholipase C-γ2 (p-PLC-γ2). Both were increased by AKT inhibition at all time points after 1 min of stimulation (Fig. 7b) . Importantly, this effect was GCBC-specific because AKT inhibition did not significantly change the kinetics of p-BTK or p-PLC-γ2 in NBCs ( Supplementary  Fig. 5 ). These data thus reveal a mechanism by which AKT signaling in GCBCs is rewired to form a negative feedback loop acting on proximal BCR signaling and further demonstrate how this operates at multiple levels of the signaling pathway.
Discussion
We have identified molecular mechanisms behind a previously unknown feedback loop in which AKT signaling phosphorylates, --SF1670  +  +   PP2AB  CSK  RHG30  SHP1  HPK1  DOCK8  PPR18  PLCG2  BANK1  ASH2L  NC2B  CCAR1  CCNK  CK5P3  SAMH1  POLD1  FOXO1  TF2B  SIRT7  EZH2  DPOD4  BAZ1A  MSH6  IKZF3  IKZF1  RUVB2  MBD2  MCM5  SMRC1  RPAP3  SRSF5  HNRNPA0  HNRNPA3  HNRPF  HNRH1  HNRPK  U2AF1  ARP2  AP2B1 Supplementary  Fig. 3 was used to identify AKT substrates (n = 2 from two independent experiments). a, The PANTHER software package was used to identify pathways targeted by AKT in GCBCs. The heatmap shows the relative protein abundance by normalizing the peak area for each experimental group to the maximum peak area observed for each protein. 
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and thereby activates, three distinct upstream negative regulators of BCR signaling. This negative feedback loop is found only in GCBCs, not NBCs, presumably because AKT targeting itself is redirected within GCBCs. We further linked the redirection of AKT target specificity in GCBCs to reductions in AKT p-S473, but not p-T308. These GCBC alterations were PTEN dependent, as they were reversed by PTEN inhibition. Indeed, we found that GCBCs expressed substantially more PTEN than did NBCs. This was consequential for PI3K signaling in response to BCR ligation, because GCBCs generated substantially greater amounts of PtdIns(4,5) P 2 than did NBCs. Notably, these differences were at least partly attributable to PTEN because PTEN inhibition in GCBCs increased the generation of PtdIns(3,4,5)P 3 and reduced the generation of PtdIns(4,5)P 2 in response to BCR stimulation. Commensurate with this, PTEN inhibition also increased AKT p-S473 and downstream AKT signaling, as measured by p-S6 generation. Finally, we closed the loop by demonstrating that inhibition of AKT enhanced upstream BCR signaling in GCBCs, but did not affect NBCs. A schema for how GCBCs BCR signaling is remodeled via this AKT feedback is shown in Supplementary Fig. 6 .
Our finding that PTEN inhibition altered PtdIns(3,4,5)P 3 / PtdIns(4,5)P 2 ratios after BCR ligation strongly implicates PTEN as a lynchpin controlling differential responses of GCBCs versus NBCs. Indeed, PTEN expression and/or induction has also been implicated during responses to low-or high-dose TCR signaling that leads in turn to regulatory T (T reg ) or T effector cell generation in vitro 40 . PTEN has also been connected to maintaining B cell anergy 41 . SHIP-1, which generates PtdIns(3,4)P 2 from PtdIns(3,4,5) Articles NATuRE IMMuNoLoGY P 3 , could also play a role 42, 43 ; SHIP-1 is hyperphosphorylated and thereby more likely to be active in GCBCs compared with NBCs 15 . In line with our previous finding, we found here that PTEN inhibition also increased PtdIns(3,4)P 2 on BCR stimulation, further suggesting that PI3K in GCBCs is functional, but overridden by its key regulatory phosphatases. Finally, there is probably a 'forward reaction' to generate PtdIns(4,5)P 2 that occurs downstream of BCR ligation in both NBCs and GCBCs 44, 45 . How does the generation of different amounts of PtdIns(3,4,5)P 3 connect to differences in phosphorylation of AKT? We propose that the different affinities of PH domains in PDK1 and in Sin1 (part of the TORC2 complex that is the kinase for AKT-S473) can explain why, under limiting degrees of PI3K-dependent PtdIns(3,4,5)P 3 generation, AKT-T308 is preferentially phosphorylated. The affinity of PDK1 for PtdIns(3,4,5)P 3 is ~ 1.6 nM, whereas that of Sin1 for PtdIns(3,4,5)P 3 is ~141 nM 23, 24 . Thus, PDK1 will activate at substantially lower levels of PtdIns(3,4,5)P 3 generation compared with Sin1 (mTORC2) and so T308 phosphorylation will occur selectively on minimal PI3K activation. Further, in GCBCs, a low concentration of PtdIns(3,4,5)P 3 is partly compensated for by increased amounts and activity of PDK1 that, in turn, can generate AKT p-T308. In this scenario, the amount of PtdIns(3,4,5)P 3 generated by BCR ligation in GCBCs is at the lower end of the dose-response curve for mTORC2 activation. Consistent with this, we found that p-S473 generation was sensitive to PTEN inhibitor-based PtdIns(3,4,5)P 3 modulation in GCBCs.
Our findings point to a mechanism of PI3K signal diversification that explains how different analogue levels of signaling (that is, different degrees of PtdIns(3,4,5)P 3 generation) are translated into meaningfully different biological outcomes of AKT-mediated signal transduction. We propose that the differential phosphorylation of the two major activating sites on AKT, as observed in GCBCs versus NBCs, is a key factor in redirecting target specificity. This concept was previously supported in other cell types 31 , albeit not B cells, by a genetic approach that demonstrated that T308 and S473 phosphorylation endowed AKT with different capabilities to phosphorylate distinct substrates. Analogously, in T reg cell generation and function, TCR signal strength is correlated with differential p-T308 versus p-S473 phosphorylation, with a stronger signal needed for generating p-S473. A weaker signal generates T reg cells and this in turn correlates with different AKT substrate specificity 29 . T reg cell activation leads to only AKT p-T308, whereas phosphorylation of both T308 and S473 leads to the loss of T reg cell suppressive function 46 . We previously showed that BCR signals can induce a transient phosphorylation of AKT at S473, which then allows AKT to mediate efficient FOXO1 phosphorylation 16 . Here, using newly available reagents, we found that GCBCs spontaneously have detectable AKT p-T308. These findings help explain the prior finding that dual AKT phosphorylation is required for FOXO1 inactivation 16, 31 , because in GCBCs p-T308 is already present, whereas p-S473 is BCR signal inducible. It is likely that mTORC1 signals are also regulated differently in GCBC versus NBC. There could be several mechanisms by which mTORC1 signaling is altered in GCBCs. As one example, we found GCBCs have very high amounts of phosphorylated AMPactivated protein kinase (p-AMPK), which is known to inhibit mTORC1 activity (our unpublished observations).
The mechanisms underlying how the balance of phosphorylation at T308 and S473 affects substrate specificity are not yet elucidated: phosphorylation could modulate substrate affinity, enzyme kinetics (thus favoring either high-affinity substrates or a broader distribution), AKT localization or binding to cofactors. Other factors may also contribute to alteration of phosphorylation states of AKT targets, including differential expression of phosphatases that sculpt the steady-state representation of AKT target phosphorylation states 47 .
It was noteworthy that AKT target specificity was so pervasively altered in GCBCs compared with NBCs. The retargeting of kinase activity is a powerful way to coordinately change signaling and responses without changing gene expression of the kinase itself. This novel aspect of the differential signaling mechanisms of GCBCs and NBCs is likely to be used in other cell types and contexts. Hence our datasets of differentially AKT-phosphorylated targets will represent a resource for future exploration, enabling further understanding of PI3K/AKT signal transduction. Although AKT phosphorylates a wide variety of targets 48 , relatively little is known of the details or functional consequences of such events. Strikingly, all of the identified negative regulators studied here are AKT substrates for which we could find no published reports nor their inclusion in the PhosphoSitePlus database (https://www.phosphosite.org) 49 . Thus, we have also added meaningfully to understanding AKT function, as well as how activities of CSK, SHP-1 and HPK1-enzymes that themselves regulate multiple signaling pathways in diverse cell types-are regulated in a signal-dependent fashion.
Our results advance prior studies that have shed light on how BCR signaling is negatively regulated in GCBCs. Initially, we showed that general phosphatase activity was high in GCBCs and provided evidence that SHP-1 and SHIP-1 were in a more phosphorylated and thus more activated state 15 . We also found increased Ser/Thr phosphatase enzymatic activity in GCBCs lysates but did not implicate any specific phosphatase 15 . Here, we directly implicate the dual-specificity phosphatase PTEN, which is most well-known for its inositol phosphatase activity, but which also dephosphorylates Ser/Thr and Tyr-linked phosphate groups 50 . Others have also investigated GC-specific BCR-negative regulation. He et al. 51 found that immunoglobulin E (IgE) BCRs in the GC were particularly unfit to transmit needed signals and thus IgE GCBCs were strongly selected against. Haniuda et al. 52 attributed this to inherent signaling differences in the IgE ectodomain. Zikherman and colleagues 32 used a Nur77-GFP reporter that, although confirming that GCBCs overall have reduced BCR signaling, allowed them to identify a subset of GCBCs with LZ phenotype that showed a higher degree of BCR signals. It will be intriguing to connect our current mechanistic studies to determine how AKT signals may be affected in such Nur77 . Together, these studies reveal several mechanisms and contexts for rewiring BCR signal transduction.
Negative feedback loops are typically mediated within the same protein or by interaction with a protein that is adjacent in the pathway. A relevant example includes BCR signal-dependent phosphorylation of SHP-1 that, in turn, activates SHP-1 to dephosphorylate SYK/LYN and complete the feedback 15, 35, 57 . The AKT-dependent GCBCs circuit delineated here is unusual in that AKT targets and activates not one but several negative regulators of BCR signaling that are topologically upstream of AKT itself.
In total, these studies define mechanistically how BCR signaling is rewired in GCBCs and, in addition, report previously unknown functions and substrates of AKT. Both of these observations will also serve as models for further investigation in analogous systems and cell types because it is likely that these paradigms will operate more widely beyond BCR signaling in GCBCs. 
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Methods
Mice and immunization. B1-8i
+/− BALB/c (referred to as B1-8i), B1-8i
BALB/c and IgM B1-8i BCR transgenic BALB/c (referred to as MEG) mice were previously described 15, 58, 59 . Mice of all strains were used as sources of GCBCs and NBCs, as indicated in the figure legends. Mice were maintained under specificpathogen-free conditions supervised by the University of Pittsburgh Institutional Animal Care and Use Committee. Six-to 12-week-old, age-and sex-matched mice were immunized intraperitoneally with 50 μg 4-hydroxy-3-nitrophenylacetylchicken gamma globulin (NP-CGG) precipitated in Alum. Mice were analyzed at days 13-14 postimmunization or as otherwise indicated in the figure legends.
Cell preparation and treatment. NBCs were purified from unimmunized mice and GCBCs were purified from days 13-14 NP-CGG-immunized mice. The cell purification process was performed as previously described 16 . In brief, splenic NBCs were purified by negative selection using a biotin-conjugated antibody cocktail (antibodies to CD43, CD4, CD8, CD11b, CD11c, Gr-1 and CD138), followed by magnetic bead depletion of labeled cells (B cell purity ≥ 95%). For GCBC purification from B1-8i mice, biotin-conjugated anti-IgD and anti-CD38 were added to the B cell purification cocktail; for GCBC purification from MEG mice, biotin-conjugated anti-CD38 was added to the B cell purification cocktail (GCBC purity ≥ 90%). Purified cells or total splenocytes were warmed to 37 °C with 5% CO 2 in B cell medium (RPMI 1640 medium supplemented with 10% FBS, penicillin/streptomycin, glutamine and 50 μM β-mercaptoethanol) for 30-40 min and stimulated with 20 μg ml −1 goat anti-mouse IgM (μ-chain specific; Jackson ImmunoResearch) or 200 ng ml −1 NP-Ficoll (LGC Biosearch Technologies) as indicated in the figure legends. Endotoxin was removed from antibodies used for stimulation with ToxinEraser Endotoxin Removal Kit (GenScript) and endotoxin levels were tested with an LAL assay kit (GenScript) (endotoxin < 0.5 EU ml
−1
). For experiments using inhibitors, cells were treated with 10 μM AKT1/2 kinase inhibitor (Calbiochem) or 10 μM PTEN inhibitor (SF1670; Calbiochem) dissolved in DMSO or the same amount of DMSO alone, as described in the figure legends, before stimulation. For experiments measuring basal amounts of protein expression or phosphorylation, purified cells were analyzed immediately after purification.
For AKT phosphosubstrate antibody immunoblotting, the different cell populations were sorted by FACSAria (BD Immunocytometry Systems). The gating strategy of sorting and postsort testing is shown in Supplementary  Fig. 1b . In brief, NBCs were identified as CD19 +
CD93
-live singlets, in vivo-and in vitro-activated B cells as CD19 + CD86 + live singlets with increased forward scatter and GCBCs were defined as CD19 + CD95 + CD38 -live singlets. Purification led in general to more than 98% purity of target cell populations. To generate in vitroactivated B cells, magnetic bead-purified NBCs (as described earlier) were cultured in RPMI 1640 media in the presence of 5 μg ml Immunoblot analysis. Whole-cell lysates were prepared by direct lysing and boiling samples in Laemmli buffer supplemented with β-mercaptoethanol. For the experiment in Supplementary Fig. 2 , the same numbers of GCBCs and NBCs were lysed in radioimmunoprecipitation assay buffer supplemented with protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). Protein concentrations were measured with a BCA Protein Assay Kit (Pierce) and equal amounts of protein were loaded in SDS-PAGE gels for immunoblot. The samples were then blotted with the following antibodies to Actin (clone: C4/ actin; BD Biosciences), total extracellular signal-regulated kinase 1/2 (ERK1/2) (clone: Fig. 1a ).
Measurement of phosphatidylinositol abundance.
A total of 1 × 10 6 B cells were collected per time point. Samples were processed per the manufacturers' instructions included in the Echelon Biosciences Mass ELISA kits for PtdIns(4,5) P 2 (K-4500), PtdIns(3,4,5)P 3 (K-2500s) and PtdIns(3,4)P 2 (K-3800). The mass ELISA assays were measured at 450 nM on a Molecular Devices SpectraMax i3 plate reader. The standard curve was fit assuming a sigmoidal dose-response with variable slope and the amount of phosphatidylinositol in each sample was extrapolated in the GraphPad Prism 7 software package.
Immunoprecipitation of AKT substrates and mass spectrometric analysis. A total of 2 × 10 6 B cells were collected and lysed with a buffer containing 25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 5% glycerol that was supplemented with Roche Complete C protease and PhosSTOP phosphatase inhibitors. Lysates were sonicated and centrifuged to remove insoluble debris, and the remaining lysate was incubated with magnetic bead-conjugated AKT phosphosubstrate antibody (clone: 110B7E; catalog No. 8050; Cell Signaling Technologies) for 12 h at 4 °C. The beads were washed twice with lysis buffer and proteins were eluted from the beads with 8 M urea (U5128; Sigma) and 0.1 M Tris-HCl at pH 8.5. The filter-aided sample preparation method was used to generate tryptic peptides and desalted using C18 spin columns 61 . Peptides were suspended in 0.1% formic acid and resolved with liquid chromatography tandem mass spectrometry using a system composed of a Waters nanoACQUITY HPLC in-line with either an LTQ/OrbitrapVelos Elite hybrid mass spectrometer (Thermo Fisher) or a Q Exactive mass spectrometer (Thermo Fisher). Solvent A (0.1% formic acid in HPLC-grade water) and solvent B (0.1% formic acid in 100% acetonitrile) were used as the mobile phase. Peptides were then eluted onto a capillary column (75 μm inner diameter × 360 μm outer diameter × 15 cm long; Polymicro Technologies) 5-μm particle size, 125 pore size C-18 silica-bonded stationary phase (Phenomenex) and resolved using a 100-min gradient at the flow rate of 0.2 μl min −1 (3-33% B for 90 min, 33-80% B for 2 min, constant at 80% B for 6 min, and then 80-0% B for 2 min to equilibrate the column). Data were collected in positive ionization mode. PEAKS8 software was used to sequence and identify peptides in each sample using a decoy search at a 1% false discovery rate using the UniProt murine database. Label-free quantitation was performed using the quantitative module in the PEAKS8 software.
Bioinformatics. The following criteria were used to identify AKT substrates enriched in different cell types: (1) peptide(s) corresponding to a protein had to be identified in a sample type in the mass spectrometric analysis; and (2) if a given substrate was identified in multiple sample groups, its abundance had to be more than 3-fold greater based on the label-free quantitation of the mass spectrometric data to be assigned as specific to a group(s). The PANTHER pathway analysis software was used to perform a statistical overrepresentation test to identify biological pathways that were differentially targeted by AKT in the NBCs and GCBCs 62 .
AKT co-immunoprecipitation analysis. NBCs or GCBCs were activated with anti-IgM in the presence or absence of 10 μM AKT1/2 kinase inhibitor (Calbiochem). Cells were lysed in a buffer containing 25 mM Tris-HCl, pH 7. 
Software and code
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Data collection
Flow sorting data was collected using BD Diva software on BD LSRII or BD LSRFortessa flow cytometer. Mass spectrometry data was collected using standard software provided by ThermoFisher.
Data analysis
Flow cytometry data analysis was performed using Flow Jo (Treestar) software version 10. Quantitation of western blotting was performed with ImageJ software. Statistical analysis was performed using Graphpad Prism version 7.
Mass spectrometric data analysiswas performed by commercially available Peaks8.0 software. The pathway analysis was performed with Panther14.0 software. Heatmaps were generated using the Morpheus software (https://software.broadinstitute.org/morpheus).
For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
Data
Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:
-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability
Raw mass spectra will be deposited in the PRIDE repository and be freely available. Figure 3 , 4 and 6 are based on the associated mass spectra.
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Sample size
No statistical methods were used to determine samples size. Sample size was determined to be adequate based on the reproducibility between independent experiments. Sample size was also based on field standards to avoid unethical use of mice. For experiments involving magnetic beads purification of NBCs and GCBCs, each sample contained cells pooled from multiple mice to ensure adequate cell number as well as high cell quality and purity.
Data exclusions We cropped immunoblot images based on the molecular weight of the protein of interest. No other data was excluded.
Replication
At least two independent experiments were taken and all experiments were reliably reproduced. The reproducibility was based on the magnitude and consistency of measurable differences between samples.
Wild animals
The study did not involve wild animals.
Field-collected samples
The study did not involve Field-collected samples.
Ethics oversight
University of Pittsburgh IACUC approved Note that full information on the approval of the study protocol must also be provided in the manuscript.
Flow Cytometry Plots
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Methodology Sample preparation
Total mouse splenocytes were generated by mashing between frosted glass slides. Red blood cells were lysed with AKC lysis buffer. For phospho-flow cytometry, cells were fixed and permeabilized in saponin-based Perm/Wash buffer (Cat#: 554732, BD Biosciences) supplemented with 1.5% paraformaldehyde (PFA) for 10 minutes at room temperature followed by 30 minutes on ice. For experiments focused on detecting basal level of phosphorylation, cells were fixed by directly disrupting spleens into
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RPMI containing 1.5% PFA and incubating for 15 minutes at room temperature ("instant fix"). Cell population abundance B cell subsets were sorted on a BD FACS Aria machine. Post sort samples were analyzed on the same FACS Aria machine indicating greater than 98% purity for sorted subsets. Cells used in some experiments were purified by magnetic beads and tested by flow cytometry to have >90% purity.
Gating strategy
For phospho-flow cytometry: GCBCs were gated as B220+ λ+ PNA+ (or CD95+) cells, non-GCBCs were gated as B220+ λ+ PNA-(or CD95-) cells and NBCs were gated as B220+ λ-PNA-(or CD95-) cells.
For sorting different B cell populations: NBCs were identified as CD19+ CD93-live singlets; in vivo and in vitro activated B cells as CD19+ CD86+ live singlets with increased forward scatter; GCBCs were defined as CD19+, CD95+, CD38-live singlets. For For sorting different B cell populations: NBCs were identified as CD19+ CD93-live singlets; in vivo and in vitro activated B cells as CD19+ CD86+ live singlets with increased forward scatter; GCBCs were defined as CD19+, CD95+, CD38-live singlets.
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
